期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
补肾解毒通络法调控骨髓间充质干细胞上调促造血基因表达阻抑白血病复发机制研究 被引量:4
1
作者 刘姚姚 杨福军 +3 位作者 王兴丽 闫理想 张伟锋 杨向东 《中华肿瘤防治杂志》 CAS 北大核心 2021年第6期449-455,共7页
目的本研究通过临床观察及动物研究,初步探讨补肾解毒通络法保护造血干细胞龛肿瘤化阻抑白血病复发的作用机制。方法收集2013-05-09-2019-03-20天津中医药大学第一附属医院血液科住院治疗的复发/难治性急性白血病患者,分为西药对照组、... 目的本研究通过临床观察及动物研究,初步探讨补肾解毒通络法保护造血干细胞龛肿瘤化阻抑白血病复发的作用机制。方法收集2013-05-09-2019-03-20天津中医药大学第一附属医院血液科住院治疗的复发/难治性急性白血病患者,分为西药对照组、中药非补肾解毒通络组和中药补肾解毒通络组,比较各组生存期、总有效率,分析补肾解毒通络法优势作用。选取C57小鼠随机分为正常对照组、模型照射组、补肾解毒通络组和补肾解毒通络照射组,每组8只。射线予5 Gyγ射线照射,予生理盐水与补肾解毒通络汤剂等剂量连续灌胃28 d,分离各组骨髓间充质干细胞(BM-MSCs),并与K562白血病细胞共培养24 h后,CCK-8检测K562细胞增殖,FCM检测K562细胞凋亡和周期;qRT-PCR检测MSCs中Cxcl12、Jagged-1和Scf基因表达。结果生存期>3年中药补肾解毒通络组36.3%(12/33),中药非补肾解毒通络组6.9%(2/29),西药对照组8%(2/25);1<生存期≤3年中药补肾解毒通络组33.3%(11/33),中药非补肾解毒通络组48.3%(14/29),西药对照组36%(9/25)。中药补肾解毒通络组能延长患者生存期,χ^(2)=7.806,P=0.020;χ^(2)=7.116,P=0.024。正常对照组、模型照射组、补肾解毒通络组和补肾解毒通络照射组粒-巨噬细胞集落克隆数分别为(31.67±2.03)、(29.31±3.46)、(40.67±1.45)和(36.33±1.86)个。补肾解毒通络组和正常对照组相比,差异有统计学意义,t=2.616,P=0.031。补肾解毒通络组与正常对照组对比能促进K562细胞增殖,t=2.906,P=0.016;K562细胞凋亡率、处于G0/G1期细胞占比均未见明显差异,χ^(2)=5.607,P=0.797;χ^(2)=0.35,P=0.935。补肾解毒通络组和对照组对比,Cxcl12、Jagged-1、Scf基因表达水平明显上调。结论补肾解毒通络法可延长复发/难治性急性白血病患者生存期,通过上调间充干细胞Cxcl12、Jagged-1、Scf基因表达保护造血干细胞龛肿瘤化,发挥防止白血病复发的作用。 展开更多
关键词 补肾解毒通络法 造血干细胞龛 间充质干细胞 复发/难治急性白血病
原文传递
Fetal liver: an ideal niche for hematopoietic stem cell expansion 被引量:7
2
作者 Suwei Gao Feng Liu 《Science China(Life Sciences)》 SCIE CAS CSCD 2018年第8期885-892,共8页
Fetal liver (FL) is an intricate and highly vascularized hematopoietic organ, which can support the extensive expansion of hematopoietic stem cells (HSCs) without loss of stenmess, as well as of the downstream lin... Fetal liver (FL) is an intricate and highly vascularized hematopoietic organ, which can support the extensive expansion of hematopoietic stem cells (HSCs) without loss of stenmess, as well as of the downstream lineages of HSCs. This powerful function of FL largely benefits from the niche (or microenvironment), which provides a residence for HSC expansion. Numerous studies have demonstrated that the FL niche consists of heterogeneous cell populations that associate with HSCs spatially and regulate HSCs functionally. At the molecular level, a complex of cell extrinsic and intrinsic signaling network within the FL niche cells maintains HSC expansion. Here, we summarize recent studies on the analysis of the FL HSCs and their niche, and specifically on the molecular regulatory network for HSC expansion. Based on these studies, we hypothesize a strategy to obtain a large number of functional HSCs via 3D reconstruction of FL organoid ex vivo for clinical treatment in the future. 展开更多
关键词 fetal liver NICHE hematopoietic stem cell expansion signaling network
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部